Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HTFL
SELLHeartflow, Inc. · Healthcare · United States · $2.1B · Avg Vol: $45M/d
COMPANY DESCRIPTION
Heartflow, Inc. provides non-invasive, AI-powered technology to diagnose coronary artery disease (CAD), utilizing standard CT scans to create a 3D model of coronary arteries and simulate blood flow. The company's HeartFlow FFRct Analysis offers clinicians a functional assessment of blockages, reducing the need for invasive procedures and improving diagnostic accuracy. Its proprietary technology and FDA clearance establish a strong competitive position in the cardiovascular diagnostics market.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 87.2M | 125.8M | 176.0M | 42.1% | 191.4M | 230.0M | 282.8M | 26.7% |
| EPS | -1.94 | -1.20 | -3.17 | — | -3.05 | — | — | — |
| Shares | 80.6M | 80.6M | 85.3M | +5.8% | 86.2M | — | — | — |
| Debt | 160.6M | 160.4M | 22.1M | -62.9% | 26.3M | — | — | — |
| Equity | -777.6M | -859.5M | 300.6M | — | — | — | — | — |
| Op CF | -76.4M | -69.0M | -54.0M | — | -71.0M | — | — | — |
| Inv CF | -6.1M | -4.4M | -238.6M | — | — | — | — | — |
| Fin CF | 169.3M | 2.2M | 286.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HTFL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HTFL | Heartflow, Inc.(you) | $2.1B | 26 | SELL |
| SDGR | Schrödinger, Inc. | $1.1B | 14 | STRONG SELL |
| TEM | Tempus AI, Inc. | $7.7B | 19 | STRONG SELL |
| CERT | Certara, Inc. | $1.2B | 53 | HOLD |
| CARL | Carlsmed, Inc. | $294M | 24 | SELL |
| OMCL | Omnicell, Inc. | $1.9B | 65 | BUY |
| PRVA | Privia Health Group, Inc. | $3.2B | 59 | HOLD |
| PHR | Phreesia, Inc. | $632M | 47 | HOLD |
| DOCS | Doximity, Inc. | $3.7B | 62 | HOLD |
| OMDA | Omada Health, Inc. | $1.2B | 63 | HOLD |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%